Clinical Trials in Gilbert, Arizona

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

NCT ID: NCT06377852

The CDK Study is a clinical trial that aims to find out if a different way of giving certain cancer medications, known as CDK4/6 inhibitors, can help older patients with metastatic breast cancer (M...

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

NCT ID: NCT06562543

This clinical trial is investigating the safety and effectiveness of a medication called fruquintinib in minority groups, specifically Black or African American and Hispanic or Latino adults, who h...

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

NCT ID: NCT06629779

This clinical trial is studying a new drug called PF-06821497 (also known as Mevrometostat) to see if it works better when combined with another medication called enzalutamide for men with metastat...

Selatogrel Outcome Study in Suspected Acute Myocardial Infarction

NCT ID: NCT04957719

A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)

NCT ID: NCT06356311

This clinical trial is studying a new treatment called sacituzumab tirumotecan (MK-2870) for patients with advanced or metastatic gastroesophageal adenocarcinoma, which is a type of cancer affectin...

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

NCT ID: NCT05894239

This clinical trial is studying a new treatment for patients with a specific type of advanced breast cancer known as HER2-positive metastatic breast cancer. The researchers want to find out if a dr...

A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

NCT ID: NCT06497556

This clinical trial is studying a new treatment called divarasib for patients with advanced or metastatic non-small cell lung cancer (NSCLC) that has a specific mutation known as KRAS G12C. The goa...

MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

NCT ID: NCT05090566

The MagnetisMM-4 study is looking at a new treatment called elranatamab, which is being tested alongside other cancer therapies for people with multiple myeloma, a type of blood cancer. The main go...

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56

NCT ID: NCT06683742

The LUCIA trial is a study designed to test a new treatment called EYP-1901 for people with wet age-related macular degeneration (wAMD), a condition that can lead to vision loss. This trial will co...

A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

NCT ID: NCT03574571

This clinical trial is studying a combination of two treatments, radium-223 and docetaxel, to see if they work better together for men with prostate cancer than docetaxel alone. The goal is to lear...

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

NCT ID: NCT05317416

This clinical trial is studying a new treatment called elranatamab to see if it is more effective than a standard treatment called lenalidomide for patients with newly diagnosed multiple myeloma wh...

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

NCT ID: NCT05769153

This clinical trial is investigating a new treatment called AR-14034 for patients with neovascular age-related macular degeneration (nAMD), a condition that can lead to vision loss. The main goal o...

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NCT ID: NCT04981119

This clinical trial is exploring how often certain solid tumors, like colorectal cancer and lung cancer, lose a specific gene marker called Human Leukocyte Antigen (HLA) and how this loss might aff...

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

NCT ID: NCT06433752

This clinical trial is studying the real-world experience of people with Relapsing Multiple Sclerosis (RMS) who are treated with BRIUMVI® (ublituximab-xiiy). The goal is to understand how safe and ...

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

NCT ID: NCT05429632

This clinical trial is studying a new treatment called Mocravimod for adults with Acute Myeloid Leukemia (AML) who are preparing to undergo a stem cell transplant from a donor. The goal is to see i...

Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

NCT ID: NCT06840392

This clinical trial is investigating the effectiveness and safety of a medication called remibrutinib for adults with moderate to severe hidradenitis suppurativa (HS), a skin condition that causes ...

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

NCT ID: NCT07000357

This clinical trial is studying a medication called AZD0780 to see if it can help reduce serious heart-related events in patients who have a history of cardiovascular disease or are at high risk fo...

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

NCT ID: NCT06120491

This clinical trial is investigating a new treatment called Saruparib (AZD5305) for men with metastatic castration-sensitive prostate cancer, which means their cancer has spread but still responds ...

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

NCT ID: NCT03175224

The APL-101 clinical trial is exploring a new treatment for patients with advanced lung cancer, specifically those with certain genetic changes called c-Met Exon 14 skipping mutations or MET amplif...

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

NCT ID: NCT03435796

This clinical trial is focused on following up with patients who have received a special treatment called gene-modified T cell therapy for cancer. The study aims to gather information about the lon...